Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock

Michael Ombrellino, Haichao Wang, Michael S. Ajemian, Akram Talhouk, Larry A. Scher, Steven G. Friedman, Kevin J. Tracey

Research output: Contribution to journalArticle

154 Citations (Scopus)

Abstract

Serum concentrations of high-mobility-group protein 1 (HMG1) were increased during an episode of haemorrhagic shock in a patient who had undergone repair of an abdominal aortic aneurysm. HMG1 may be involved in the pathogenesis of human haemorrhagic shock.

Original languageEnglish (US)
Pages (from-to)1446-1447
Number of pages2
JournalLancet
Volume354
Issue number9188
DOIs
StatePublished - Oct 23 1999

Fingerprint

High Mobility Group Proteins
Hemorrhagic Shock
Abdominal Aortic Aneurysm
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ombrellino, M., Wang, H., Ajemian, M. S., Talhouk, A., Scher, L. A., Friedman, S. G., & Tracey, K. J. (1999). Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. Lancet, 354(9188), 1446-1447. https://doi.org/10.1016/S0140-6736(99)02658-6

Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. / Ombrellino, Michael; Wang, Haichao; Ajemian, Michael S.; Talhouk, Akram; Scher, Larry A.; Friedman, Steven G.; Tracey, Kevin J.

In: Lancet, Vol. 354, No. 9188, 23.10.1999, p. 1446-1447.

Research output: Contribution to journalArticle

Ombrellino, M, Wang, H, Ajemian, MS, Talhouk, A, Scher, LA, Friedman, SG & Tracey, KJ 1999, 'Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock', Lancet, vol. 354, no. 9188, pp. 1446-1447. https://doi.org/10.1016/S0140-6736(99)02658-6
Ombrellino M, Wang H, Ajemian MS, Talhouk A, Scher LA, Friedman SG et al. Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. Lancet. 1999 Oct 23;354(9188):1446-1447. https://doi.org/10.1016/S0140-6736(99)02658-6
Ombrellino, Michael ; Wang, Haichao ; Ajemian, Michael S. ; Talhouk, Akram ; Scher, Larry A. ; Friedman, Steven G. ; Tracey, Kevin J. / Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. In: Lancet. 1999 ; Vol. 354, No. 9188. pp. 1446-1447.
@article{83dcce260a494789a0ac54365b3d812d,
title = "Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock",
abstract = "Serum concentrations of high-mobility-group protein 1 (HMG1) were increased during an episode of haemorrhagic shock in a patient who had undergone repair of an abdominal aortic aneurysm. HMG1 may be involved in the pathogenesis of human haemorrhagic shock.",
author = "Michael Ombrellino and Haichao Wang and Ajemian, {Michael S.} and Akram Talhouk and Scher, {Larry A.} and Friedman, {Steven G.} and Tracey, {Kevin J.}",
year = "1999",
month = "10",
day = "23",
doi = "10.1016/S0140-6736(99)02658-6",
language = "English (US)",
volume = "354",
pages = "1446--1447",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9188",

}

TY - JOUR

T1 - Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock

AU - Ombrellino, Michael

AU - Wang, Haichao

AU - Ajemian, Michael S.

AU - Talhouk, Akram

AU - Scher, Larry A.

AU - Friedman, Steven G.

AU - Tracey, Kevin J.

PY - 1999/10/23

Y1 - 1999/10/23

N2 - Serum concentrations of high-mobility-group protein 1 (HMG1) were increased during an episode of haemorrhagic shock in a patient who had undergone repair of an abdominal aortic aneurysm. HMG1 may be involved in the pathogenesis of human haemorrhagic shock.

AB - Serum concentrations of high-mobility-group protein 1 (HMG1) were increased during an episode of haemorrhagic shock in a patient who had undergone repair of an abdominal aortic aneurysm. HMG1 may be involved in the pathogenesis of human haemorrhagic shock.

UR - http://www.scopus.com/inward/record.url?scp=0033598645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033598645&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(99)02658-6

DO - 10.1016/S0140-6736(99)02658-6

M3 - Article

VL - 354

SP - 1446

EP - 1447

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9188

ER -